Catalent Pharma Solutions Inc is categorized under Drugs, Proprietaries, and Sundries in San Diego, CA .
Catalent Pharma Solutions Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Richard Kenley at the company’s branch by writing to 9240 Trade Place # 100, San Diego, California CA 92126 or by phoning (858) 547-7800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Catalent Pharma Solutions Inc |
| Contact Person: | Richard Kenley |
| Address: | 9240 Trade Place # 100, San Diego, California 92126 |
| Phone Number: | (858) 547-7800 |
| Website Address: | catalent.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Catalent Pharma Solutions Inc was started in 0 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Richard Kenley for inquiries that concern Catalent Pharma Solutions Inc by calling the company number (858) 547-7800, as your correspondence is most welcome. Additionally, the physical location of the branch of Catalent Pharma Solutions Inc can be found at the coordinates as well as the street address 9240 Trade Place # 100 in San Diego, California 92126.
For its online presence, you may visit Catalent Pharma Solutions Inc’s website at catalent.com and engage with its social media outlets through on Twitter and on Facebook.